On this page
What each program costs in Rhode Island
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the State of Rhode Island Anchor Plan (active employees) cover GLP-1s for weight loss?
Rhode Island's Anchor Plan benefit booklet for active state employees, administered by Blue Cross & Blue Shield of Rhode Island, excludes prescribed weight-loss drugs unless they are a listed covered service or come through a program offered with the plan.
Rhode Island Office of Employee Benefits
The 2026 Anchor Plan benefit booklet lists prescribed weight-loss drugs among its exclusions, with a carve-out for covered services and plan programs.
“Prescribed weight-loss drugs unless included as a covered healthcare service or provided through a program offered with your plan.”
https://employeebenefits.ri.gov/sites/g/files/xkgbur816/files/2026-10/Anchor%20Plan%20-%20Active%20Ratified-%202026%20-%20MHM03387.pdf · read Oct 29, 2026
Rhode Island Office of Employee Benefits
The same booklet also excludes weight-loss programs unless listed as covered or offered with the plan.
“Programs or drugs designed for the purpose of weight loss, including but not limited to, commercial diet plans, weight loss programs, and any services in connection with such plans or programs, unless listed as a covered healthcare service or offered as a program with your plan.”
https://employeebenefits.ri.gov/sites/g/files/xkgbur816/files/2026-10/Anchor%20Plan%20-%20Active%20Ratified-%202026%20-%20MHM03387.pdf · read Oct 29, 2026
Does Rhode Island Medicaid cover GLP-1s for weight loss?
Not confirmed
We could not read Rhode Island Medicaid's own notice, so its coverage of Wegovy and Zepbound for weight loss is not confirmed. KFF listed it as covering them in January 2026, a dated secondary source. A Rhode Island health plan says the state's fiscal 2027 budget ended this coverage, effective October 1, 2026, so that change may have taken effect.
“Pursuant to the Rhode Island State Fiscal Year 2027 Enacted Budget, Rhode Island Medicaid will no longer cover certain GLP-1 receptor agonists when they are prescribed solely for weight loss”
Tufts Health RITogether provider notice, September 2026 (a health plan, not the state) · read Nov 6, 2026
Weight loss
Not confirmed
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
12,691 prescriptions
Ozempic and Mounjaro, 2025
28,440 prescriptions
Neighbours covering weight loss
0 of 2
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. KFF counts coverage under fee-for-service; if your Rhode Island Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
What may have changed since January
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Rhode Island Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Rhode Island Medicaid pay for?
46,691 GLP-1 prescriptions in 2025, 37th of the 50 states and DC, with $48.8 million reimbursed before rebates. Counting the share other payers covered, $48.9 million.
Prescriptions, 2025
46,691
37th of 51
Medicaid paid
$48.8M
36th of 51, before rebates
Per prescription
$1,046
$1,051 nationally
Weight-loss brands
27%
14th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Rhode Island is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 27% of Rhode Island Medicaid's GLP-1 prescriptions in 2025 (12,691). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Ozempic was Rhode Island Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Ozempic | 21,489 | 46% | $21.0 million | $977 |
| Mounjaro | 6,951 | 15% | $7.4 million | $1,070 |
| Wegovyapproved for weight management | 6,899 | 15% | $9.0 million | $1,300 |
| Zepboundapproved for weight management | 5,636 | 12% | $5.9 million | $1,052 |
| Trulicity | 4,072 | 8.7% | $3.9 million | $966 |
| Rybelsus | 1,291 | 2.8% | $1.3 million | $973 |
| Liraglutide (generic) | 197 | 0.4% | $123,048 | $625 |
| Saxendaapproved for weight management | 156 | 0.3% | $180,369 | $1,156 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
On Medicare in Rhode Island?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Rhode Island and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
None of the 2 states next to Rhode Island covers GLP-1s for weight loss through Medicaid. None has a lower cash floor than Rhode Island's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Rhode Island | Not confirmed | 19 | $39/mo |
| Connecticut | Not covered | 19 | $39/moWellmedr |
| Massachusetts | Not covered | 18 | $39/moWellmedr |






















